The Analysis of Bleeding Risk-Prediction Scores Should Include All Major Bleeds

被引：1
|
作者：
Gage, Brian F. [1 ]
Radford, Martha J. [1 ]
机构：
[1] Washington Univ, Sch Med, St Louis, MO 63110 USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2013年 / 61卷 / 04期
关键词：
D O I：
10.1016/j.jacc.2012.09.053
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：481 / 482
页数：2
相关论文
共 50 条
  • [11] Performance of the HEMORR2HAGES, ATRIA, and HAS-BLED Bleeding Risk-Prediction Scores in Nonwarfarin Anticoagulated Atrial Fibrillation Patients
    Apostolakis, Stavros
    Lane, Deirdre A.
    Guo, Yutao
    Buller, Harry
    Lip, Gregory Y. H.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (03) : 386 - 387
  • [12] TOWARDS IMPLEMENTATION OF LIVE AI-BASED PROGNOSTIC RISK-PREDICTION SCORES IN A COPD MDT
    Burns, S.
    Subasic, G.
    Morgan, D.
    Taylor, A.
    McGinness, P.
    Lowe, D. J.
    Carlin, C.
    THORAX, 2022, 77 : A41 - A42
  • [13] Comparison of bleeding risk scores and evaluation of major bleeding predictive factors in patients with major bleeding due to vitamin K antagonist use
    Yildirim, Sinan
    Aslan, Onur
    HELIYON, 2023, 9 (08)
  • [14] Should future risk-of-fracture analyses include another major risk factor? The case for falls
    Frost, HM
    JOURNAL OF CLINICAL DENSITOMETRY, 2001, 4 (04) : 381 - 383
  • [15] Modest performance of risk-prediction models for anticoagulant-related bleeding in patients with chronic liver disease
    Afzal, Amber
    Gage, Brian F.
    Luo, Suhong
    Schoen, Martin
    Sanfilippo, Kristen M.
    THROMBOSIS RESEARCH, 2024, 237 : 138 - 140
  • [16] Reporting the NAFT major bleeding rates in context: Reviewers should include site investigator-classified rates
    Hull, RD
    Mall, AF
    ARCHIVES OF INTERNAL MEDICINE, 2003, 163 (03) : 369 - 369
  • [17] Prospective, multicenter validation of prediction scores for major bleeding in elderly patients with venous thromboembolism
    Scherz, N.
    Mean, M.
    Limacher, A.
    Righini, M.
    Jaeger, K.
    Beer, H. -J.
    Frauchiger, B.
    Osterwalder, J.
    Kucher, N.
    Matter, C. M.
    Banyai, M.
    Angelillo-Scherrer, A.
    Laemmle, B.
    Husmann, M.
    Egloff, M.
    Aschwanden, M.
    Bounameaux, H.
    Cornuz, J.
    Rodondi, N.
    Aujesky, D.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 (03) : 435 - 443
  • [18] Genetic polymorphisms and major bleeding risk during vitamin K antagonists treatment: The BLEEDS case-cohort
    Camilleri, Eleonora
    Ghobreyal, Mira
    Bos, Mettine H. A.
    Reitsma, Pieter H.
    Van Der Meer, Felix J. M.
    Swen, Jesse J.
    Cannegieter, Suzanne C.
    van Rein, Nienke
    PHARMACOTHERAPY, 2024, 44 (06): : 416 - 424
  • [19] Comparison of Four Bleeding Risk Scores to Identify Rivaroxaban-treated Patients With Venous Thromboembolism at Low Risk for Major Bleeding
    Kline, Jeffrey A.
    Jimenez, David
    Courtney, D. Mark
    Ianus, Juliana
    Cao, Lynn
    Lensing, Anthonie W. A.
    Prins, Martin H.
    Wells, Philip S.
    ACADEMIC EMERGENCY MEDICINE, 2016, 23 (02) : 144 - 150
  • [20] Comparison of CRUSADE and ORBIT bleeding risk scores in prediction of mayor bleeding in pacients with acute coronary syndrome
    Chirino, D.
    Vitale, F.
    Iglesias, J.
    Leonardi, M.
    Vazquez, M. L. Rodriguez
    Calderon, G.
    Dizeo, C.
    EUROPEAN HEART JOURNAL, 2022, 43 : 1328 - 1328
12345